Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A27950 | 16912563 | Curr Opin Clin Nutr Metab Care | Non-alcoholic steatohepatitis and metabolic syndrome. | 2006 | Details |
| A27961 | 16871575 | Hepatology | Statins and hepatic steatosis: perspectives from the Dallas Heart Study. | 2006 | Details |
| A27971 | 16832839 | Diabetes Metab Res Rev | Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. | 2006 | Details |
| A27990 | 16778754 | Minerva Cardioangiol | Nonalcoholic fatty liver disease and the metabolic syndrome. | 2006 | Details |
| A28005 | 16762625 | Gastroenterology | Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. | 2006 | Details |
| A28029 | 16682043 | Atherosclerosis | Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. | 2006 | Details |
| A28040 | 16620269 | Diabet Med | Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease. | 2006 | Details |
| A28056 | 16553034 | J Endocrinol Invest | Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients. | 2006 | Details |
| A28077 | 16503761 | Expert Opin Investig Drugs | Recent findings concerning thiazolidinediones in the treatment of diabetes. | 2006 | Details |
| A28133 | 16306373 | Diabetes | Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. | 2005 | Details |
| A28169 | 16231588 | Eur Rev Med Pharmacol Sci | Hepatic steatosis and vascular disease. | 2006 | Details |
| A28172 | 16231585 | Eur Rev Med Pharmacol Sci | Attraction and growing interest for the fatty liver by the scientific associations. | 2006 | Details |
| A28180 | 16225469 | Aliment Pharmacol Ther | Review article: the metabolic syndrome and non-alcoholic fatty liver disease. | 2005 | Details |
| A28196 | 16179269 | Ann Med | Is liver disease a threat to patients with metabolic disorders? | 2005 | Details |
| A28243 | 15981216 | Hepatology | Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. | 2005 | Details |
| A28252 | 15948897 | Eur J Clin Invest | Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus. | 2005 | Details |
| A28269 | 15867021 | Pediatrics | Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. | 2005 | Details |
| A28306 | 15731489 | Arterioscler Thromb Vasc Biol | Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. | 2005 | Details |
| A28370 | 15385714 | Korean J Hepatol | [The prevalence of metabolic syndrome in patients with nonalcoholic fatty liver disease]. | 2004 | Details |
| A28474 | 12879992 | Clin Liver Dis | Hepatotoxicity of hypolipidemic drugs. | 2003 | Details |
| A28552 | 11475019 | Ned Tijdschr Geneeskd | [Abdominal obesity: metabolic complications and consequences for the liver]. | 2001 | Details |
| A28553 | 11473047 | Diabetes | Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. | 2001 | Details |
| A28637 | 35212585 | Expert Rev Clin Immunol | Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives. | 2022 | Details |
| A28688 | 35129266 | J Clin Hypertens (Greenwich) | Estimated blood pressure trajectories and hypertension patterns among pregnant women living with HIV, Haiti, 2007-2017. | 2022 | Details |
| A28708 | 35110697 | Acta Pharmacol Sin | NASH: regulatory considerations for clinical drug development and U.S. FDA approval. | 2022 | Details |
| A28867 | 34888761 | Drugs Aging | Non-Steroidal Anti-Inflammatory Drugs and Risk of Acute Kidney Injury and Hyperkalemia in Older Adults: A Retrospective Cohort Study and External Validation of a Clinical Risk Model. | 2021 | Details |
| A28936 | 34797360 | Food Funct | Effects of Salvia hispanica L. (chia) seed on blood coagulation, endothelial dysfunction and liver fibrosis in an experimental model of Metabolic Syndrome. | 2021 | Details |
| A28951 | 34782294 | Surg Obes Relat Dis | Impact of metabolic surgery on cost and long-term health outcome: a cost-effectiveness approach. | 2021 | Details |
| A28984 | 34740336 | BMC Public Health | The significant places of African American adults and their perceived influence on cardiovascular disease risk behaviors. | 2021 | Details |
| A29011 | 34710147 | PLoS One | A systematic review of interventions to promote physical activity in six Gulf countries. | 2021 | Details |
| A29068 | 34626851 | Mol Metab | GLP-1 physiology informs the pharmacotherapy of obesity. | 2021 | Details |
| A29273 | 34322482 | Front Cell Dev Biol | MicroRNA-494 Regulates Endoplasmic Reticulum Stress in Endothelial Cells. | 2021 | Details |
| A29275 | 34316375 | Gastroenterol Rep (Oxf) | Bariatric surgery proves long-term benefit in patients with cirrhosis. | 2020 | Details |
| A29316 | 34262459 | Front Pharmacol | Kaempferol Alleviates Steatosis and Inflammation During Early Non-Alcoholic Steatohepatitis Associated With Liver X Receptor α-Lysophosphatidylcholine Acyltransferase 3 Signaling Pathway. | 2021 | Details |
| A29611 | 33800470 | Biomedicines | C-Peptide as a Therapy for Type 1 Diabetes Mellitus. | 2021 | Details |
| A29742 | 33590776 | Gut Microbes | The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases. | 2022 | Details |
| A29792 | 33513920 | Biomedicines | Magnesium, Little Known But Possibly Relevant: A Link between NASH and Related Comorbidities. | 2021 | Details |
| A29814 | 33465480 | Clin Gastroenterol Hepatol | Predicting Long-term Survival After Liver Transplantation in Patients With NASH Cirrhosis. | 2021 | Details |
| A29976 | 33178326 | Evid Based Complement Alternat Med | Efficacy and Mechanism of a Chinese Classic Prescription of Yueju in Treating Nonalcoholic Steatohepatitis and Protecting Hepatocytes from Apoptosis. | 2020 | Details |
| A30164 | 32875622 | J Food Biochem | Effect of cassava flour on the lipidic and redox profile of Wistar rats with dyslipidemia. | 2020 | Details |
| A30237 | 32764725 | Nat Rev Endocrinol | The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic. | 2020 | Details |
| A30290 | 32694748 | Spinal Cord | A tele-health intervention to increase physical fitness in people with spinal cord injury and cardiometabolic disease or risk factors: a pilot randomized controlled trial. | 2020 | Details |
| A30405 | 32497840 | Chemosphere | Deep learning for predicting the occurrence of cardiopulmonary diseases in Nanjing, China. | 2020 | Details |
| A30617 | 32099031 | Sci Rep | Inhibition of Grb14, a negative modulator of insulin signaling, improves glucose homeostasis without causing cardiac dysfunction. | 2020 | Details |
| A30621 | 32097195 | J Acquir Immune Defic Syndr | Mood Disorders and Increased Risk of Noncommunicable Disease in Adults With HIV. | 2020 | Details |
| A30956 | 31479766 | Nitric Oxide | Hydrogen sulfide potentiates the favorable metabolic effects of inorganic nitrite in type 2 diabetic rats. | 2019 | Details |
| A31229 | 31001415 | F1000Res | Recent advances in managing/understanding the metabolic syndrome. | 2019 | Details |
| A31276 | 30909602 | Cells | 2,4 Dinitrophenol as Medicine. | 2019 | Details |
| A31360 | 30725432 | Obes Surg | Laparoscopic Sleeve Gastrectomy After Orthotopic Liver Transplantation, Video Reported. | 2019 | Details |
| A31403 | 30637220 | J Clin Transl Hepatol | Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft. | 2018 | Details |
| A31476 | 30498706 | Visc Med | Comorbidities as an Indication for Metabolic Surgery. | 2018 | Details |
| A31566 | 30279143 | EBioMedicine | Fisetin is a senotherapeutic that extends health and lifespan. | 2018 | Details |
| A31761 | 29906969 | Phys Rev E | Mechanical perturbation control of cardiac alternans. | 2018 | Details |
| A31816 | 29765319 | Front Pharmacol | Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy. | 2018 | Details |
| A31823 | 29750655 | J Pediatr Endocrinol Metab | Metabolic risk factors in adolescent girls with type 1 diabetes. | 2018 | Details |
| A32130 | 29143759 | Antioxidants (Basel) | The Role of Food Antioxidants, Benefits of Functional Foods, and Influence of Feeding Habits on the Health of the Older Person: An Overview. | 2017 | Details |
| A32302 | 28759840 | J Mech Behav Biomed Mater | An experimental canine patent ductus arteriosus occlusion device based on shape memory polymer foam in a nitinol cage. | 2017 | Details |
| A32329 | 28707263 | Drug Deliv Transl Res | Delivery of viral vectors for gene therapy in intimal hyperplasia and restenosis in atherosclerotic swine. | 2018 | Details |
| A32378 | 28603781 | JACC Basic Transl Sci | Genome-Wide Association Studies Candidate Gene to Dual Modifier of Nonalcoholic Steatohepatitis and Atherosclerosis. | 2016 | Details |
| A32505 | 28255329 | Evid Based Complement Alternat Med | Salidroside Modulates Insulin Signaling in a Rat Model of Nonalcoholic Steatohepatitis. | 2017 | Details |
| A32604 | 28011834 | Europace | Impact of mechanical deformation on pseudo-ECG: a simulation study. | 2016 | Details |
| A32658 | 27816611 | Free Radic Biol Med | Vitamin E: Emerging aspects and new directions. | 2016 | Details |
| A32915 | 27095224 | Arch Biochem Biophys | The rise, the fall and the renaissance of vitamin E. | 2016 | Details |
| A32970 | 26956847 | Rev Endocr Metab Disord | The metabolic vascular syndrome - guide to an individualized treatment. | 2016 | Details |
| A32974 | 26946333 | Am J Transplant | Factors Associated With Major Adverse Cardiovascular Events After Liver Transplantation Among a National Sample. | 2016 | Details |
| A33056 | 26774017 | Diabetes Metab | Pleiotropic effects of insulin and GLP-1 receptor agonists: Potential benefits of the association. | 2015 | Details |
| A33353 | 26162843 | Handb Exp Pharmacol | Phosphinodithioate and Phosphoramidodithioate Hydrogen Sulfide Donors. | 2015 | Details |
| A33393 | 26069933 | Comput Biol Med | Control of cardiac alternans in an electromechanical model of cardiac tissue. | 2015 | Details |
| A33402 | 26056963 | Int J Cardiol | Diallyl trisulfide protects against high glucose-induced cardiac apoptosis by stimulating the production of cystathionine gamma-lyase-derived hydrogen sulfide. | 2015 | Details |
| A33463 | 25943712 | Hepatol Res | Morbidly obese patient with non-alcoholic steatohepatitis-related cirrhosis who died from sepsis caused by dental infection of Porphyromonas gingivalis: A case report. | 2015 | Details |
| A33468 | 25926979 | F1000Prime Rep | Recent advances in understanding/management of non-alcoholic steatohepatitis. | 2015 | Details |
| A33489 | 25888871 | Lipids Health Dis | High-salt in addition to high-fat diet may enhance inflammation and fibrosis in liver steatosis induced by oxidative stress and dyslipidemia in mice. | 2015 | Details |
| A33663 | 25474566 | Appl Physiol Nutr Metab | Ischemic preconditioning does not improve peak exercise capacity at sea level or simulated high altitude in trained male cyclists. | 2015 | Details |
| A33844 | 25036371 | J Neurotrauma | Spinal cord injury causes chronic liver pathology in rats. | 2014 | Details |
| A33941 | 24813992 | Biochem Biophys Res Commun | Therapeutic potential of flurbiprofen against obesity in mice. | 2014 | Details |
| A34157 | 26202296 | Hepatol Int | Insulin resistance: mechanism and implications for carcinogenesis and hepatocellular carcinoma in NASH. | 2013 | Details |
| A34734 | 22747994 | Microcirculation | Estimation of sinusoidal flow heterogeneity in normal and diseased rat livers from tracer dilution data using a fractal model. | 2012 | Details |
| A34863 | 22403205 | J Am Board Fam Med | Navigating change: how outreach facilitators can help clinicians improve patient outcomes. | 2012 | Details |
| A34898 | 22254299 | Annu Int Conf IEEE Eng Med Biol Soc | Cardiac alternans annihilation by distributed mechano-electric feedback (MEF). | 2011 | Details |
| A35007 | 21988197 | Hepatol Res | Angiotensinogen gene haplotype is associated with the prevalence of Japanese non-alcoholic steatohepatitis. | 2011 | Details |
| A35052 | 21865331 | Am J Clin Nutr | Effect of lectin-like oxidized LDL receptor-1 polymorphism on liver disease, glucose homeostasis, and postprandial lipoprotein metabolism in nonalcoholic steatohepatitis. | 2011 | Details |
| A35111 | 21711428 | Hepatol Res | Pharmacological therapy for non-alcoholic steatohepatitis: How efficient are thiazolidinediones? | 2011 | Details |
| A35252 | 21291347 | Expert Opin Ther Targets | Targets of chymase inhibitors. | 2011 | Details |
| A35555 | 20373454 | Liver Transpl | Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease. | 2010 | Details |
| A35676 | 19938128 | Liver Transpl | Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. | 2009 | Details |
| A35797 | 19672551 | J Gastroenterol | Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis. | 2009 | Details |
| A35864 | 19540686 | Gastroenterol Clin Biol | [Nonalcoholic fatty liver disease: 30 years research changed NASH]. | 2009 | Details |
| A36068 | 19071103 | Clin Biochem | A diagnostic model to differentiate simple steatosis from nonalcoholic steatohepatitis based on the likelihood ratio form of Bayes theorem. | 2008 | Details |
| A36079 | 19051703 | J Assoc Physicians India | Clinicopathological profile of hepatic involvement in type-2 diabetes mellitus and its significance. | 2008 | Details |
| A36236 | 18667295 | Pathophysiology | Risk factors and mechanisms of non-alcoholic steatohepatitis. | 2008 | Details |
| A36271 | 18564121 | Am J Gastroenterol | Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis. | 2008 | Details |
| A36359 | 18369343 | Obesity (Silver Spring) | NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. | 2008 | Details |
| A36534 | 17929294 | Hepatology | Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. | 2007 | Details |
| A36639 | 17547834 | Curr Diab Rep | NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes. | 2007 | Details |
| A37065 | 16535923 | Recenti Prog Med | [Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?]. | 2006 | Details |
| A37082 | 16502396 | Hepatology | Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. | 2006 | Details |
| A37220 | 16231364 | Hepatology | Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. | 2005 | Details |
| A37338 | 15922116 | Med Hypotheses | Acarbose is a promising therapeutic strategy for the treatment of patients with nonalcoholic steatohepatitis (NASH). | 2005 | Details |
| A37540 | 15460086 | Postgrad Med | Cardiovascular risk beyond LDL-C levels. Other lipids are performers in cholesterol story. | 2004 | Details |
| A37595 | 15307867 | Am J Gastroenterol | Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. | 2004 | Details |